RennieD. CONSORT revised – improving the reporting of randomized trials. JAMA2001;285:2006–7
2.
PocockSJ. Clinical Trials: A Practical Approach. Chichester, UK: John Wiley and Sons, 2002
3.
WangD, BakhaiA. Clinical Trials. A Practical Guide to Design, Analysis and Reporting. London, UK: Remedica, 2006
4.
Medical Research Council Streptomycin in Tuberculosis Trials Committee. Streptomycin treatment of pulmonary tuberculosis: a Medical Research Council investigation. BMJ1948;2:769–82
5.
MoherD, HopewellS, SchulzKF, CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ2010;340:c869
6.
AltmanDG, DoreCJ. Randomisation and baseline comparisons in clinical trials. Lancet1990;365:149–53
7.
McCarneyR, WarnerJ, IliffeS, van HaselenR, GriffinM, FisherP. The Hawthorne effect: a randomised, controlled trial. BMC Med Res Methodol2007;7:30
8.
SmithCJ. How many patients do I need? Sample size and power calculations. Phlebology2011;26:44–45
9.
SchulzKF, AltmanDG, MoherD, for the CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Int Med2010;152:726–3
10.
MooreDA, GoodallRL, IvesNJ, HookerM, GazzardBG, EasterbrookPJ. How generalizable are the results of large randomized controlled trials of antiretroviral therapy?HIV Med2000;1:149–54
